RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Assessing Relay Therapeutics (RLAY) Valuation After FDA Breakthrough Therapy Designation For Zovegalisib [Yahoo! Finance]
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer [Yahoo! Finance]
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer
Relay Therapeutics (NASDAQ:RLAY) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating.
Form 8-K Relay Therapeutics, Inc. For: Feb 03
Form 4 Relay Therapeutics, Inc. For: Jan 27 Filed by: Bergstrom Donald A
Form 4 Relay Therapeutics, Inc. For: Jan 27 Filed by: Rahmer Peter
Form 4 Relay Therapeutics, Inc. For: Jan 27 Filed by: Catinazzo Thomas
Form 4 Relay Therapeutics, Inc. For: Jan 13 Filed by: Bergstrom Donald A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.